NCT04611932View on ClinicalTrials.gov

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

March 10, 2021

Study Completion Date

April 27, 2021

Conditions
Cardiovascular Disease
Interventions
DRUG

CKD-330 Tab. and D090 Tab.

1T

DRUG

CKD-333 Tab.

1T

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY